CSIMarket
 
Arcadia Biosciences Inc   (RKDA)
Other Ticker:  
 
 
Price: $2.4800 $-0.10 -3.876%
Day's High: $2.583 Week Perf: -6.77 %
Day's Low: $ 2.41 30 Day Perf: -5.34 %
Volume (M): 668 52 Wk High: $ 6.40
Volume (M$): $ 1,658 52 Wk Avg: $3.24
Open: $2.58 52 Wk Low: $2.26



 Market Capitalization (Millions $) 28
 Shares Outstanding (Millions) 11
 Employees 47
 Revenues (TTM) (Millions $) 8
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) 2

Arcadia Biosciences Inc
We, a corporation formed in 2002, are an agricultural biotechnology trait company engaged in the development of traits that improve food, feed and fiber crops and enhance the value of the resulting agricultural products. Our customers include seed companies who incorporate these traits into their elite varieties to increase the value of a crop for farmers, as well as food and feed companies who make products that increase the choices and nutritional value of foods for consumers.


   Company Address: 202 Cousteau Place Davis 95618 CA
   Company Phone Number: 756-7077   Stock Exchange / Ticker: NASDAQ RKDA
   RKDA is expected to report next financial results on May 10, 2021.


Customers Net Income grew by RKDA's customers Net margin fell to 120.76 %

11.58 %

8.48 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AVD   -100%    
MBII   -100%    
LXU   -100%    
FMC        1.84% 
EMN        8.3% 
CF        13.3% 
• View Complete Report
   



Qualys Inc

A $2.44 million tax benefit, helped Qualys Inc to post $0.01 eps in the first quarter of 2021

A $2.44 million tax benefit, helped Qualys Inc to post $0.01 eps in the first quarter of 2021

From the preceding quarter, eps dropped by -98.29% from $0.58 per share and Sales increased by 2.06 % from $94.80 millions.

Tandem Diabetes Care Inc

Tandem Diabetes Care Inc announced first quarter of 2021 operating shortfall of $-3.237 millions

Company lost money at $-0.08 per share in the first quarter of 2021, although its Sales surged by 44.02% to $141.04 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $168.07 millions and $0.22 per share.

Arbutus Biopharma Corp

Arbutus Biopharma Corp announced fiscal time frame ending Mar 31 2021 operating shortfall of $-15.676 millions

Arbutus Biopharma Corp announced earnings per share of $-0.21 and Sales of $2.39 millions in the fiscal time frame ending Mar 31 2021, Company's decreased loss per share, versus $-0.25 eps, earned in the same quarter a year ago, although Arbutus Biopharma Corp saw its Sales rise by 41.72% in the same period.

In the previous quarter company realized Sales of $2.39 millions and $-0.23 per share.

Trane Technologies Plc

Trane Technologies Plc announced first quarter of 2021 earnings season operating income of $353.2 millions

Trane Technologies Plc announced earnings per share of $0.97 and Sales of $3.18 billions in the first quarter of 2021 earnings season, Company's earnings turn positive per share, versus $-0.12 eps, earned in the same quarter a year ago, although Trane Technologies Plc saw its Sales rise by 14.25% in the same period.

From the preceding quarter, eps decreased by -3.6% from $1.01 per share and Sales decreased by -5.08% from $3.18 billions.

Hyatt Hotels Corp

Hyatt Hotels Corp announced first quarter of 2021 operating profit of $145 millions

Hyatt Hotels Corp reported disastrous first quarter of 2021, where Sales faded by -55.89% to $438.00 millions and loss per share has widen to $-2.99, from the same quarter a year ago.

Eps decreased from the preceding quarter from $-1.99 per share, Sales increased by 3.3 % from $424.00 millions.






 

Arcadia Biosciences Inc 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LXEH's Profile

Stock Price

LXEH's Financials

Business Description

Fundamentals

Charts & Quotes

LXEH's News

Suppliers

LXEH's Competitors

Customers & Markets

Economic Indicators

LXEH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071